advisorsecurities master

FBLGFibroBiologics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
15148
Ticker
FBLG
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2024-01-31
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
FBLG

Detail

Enriched 2026-08-14 20:47

Market cap
$7,390,594.23
Shares outstanding (class)
6,658,193
Shares outstanding (weighted)
6,658,193
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
15
Location
HOUSTON, TX
Description

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data